Article info

Protocol
PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials

Authors

  1. Correspondence to Liqun Jiao; liqunjiao{at}sina.cn; Bin Yang; yangbin_81{at}163.com
View Full Text

Citation

Luo J, Liao W, Wang X, et al
PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials

Publication history

  • Received February 15, 2022
  • Accepted November 2, 2022
  • First published November 24, 2022.
Online issue publication 
December 29, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.